Back to Trials
NCT05599022NARecruiting

Randomized Assessment of TcMS for VT Storm

University of Pennsylvania

Start Date

5/22/2023

Completion Date

10/1/2028

Summary

Three-arm randomized clinical trial comparing two strategies of TcMS to sham stimulation in patients with VT storm. The hypothesis of the study is that TcMS will reduce the burden of VT in the 24 hours after randomization compared to sham stimulation and that TcMS with theta burst stimulation (TBS) will be more effective at reducing VT burden than low frequency TcMS.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * ≥3 episodes of sustained VT or appropriate ICD therapies within 24 hours despite the use of at least one antiarrhythmic drug Exclusion Criteria: * Plan for catheter ablation of VT in the next 24 hours * Pregnancy * Contraindication to TcMS (i.e. implantable ventricular assist device, metal implanted in the head or neck \[except the mouth\], implanted medication pumps, cochlear implant, implanted brain stimulator, ocular implant, history of malignancy in the neck)

Interventions

DEVICE

Magnetic Stimulation

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Ventricular Tachycardia

Locations

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania 19104

United States